−0.0413USD
−51.95 MUSD
65.62 MUSD
821.15 M
About CSTONE PHARMACEUTICALS
Sector
CEO
Jian Xin Yang
Headquarters
Shanghai
Website
Founded
2015
ISIN
KYG2588M1006
FIGI
BBG00RP1HQT3
Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. Its products include immuno-oncology drugs and molecularly targeted drugs. The company was founded on December 2, 2015, and is headquartered in Shanghai, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CSPHF is 0.1200 USD — it has increased by 0.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CSTONE PHARMACEUTICALS stocks are traded under the ticker CSPHF.
CSTONE PHARMACEUTICALS is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
CSPHF stock is 0.50% volatile and has beta coefficient of 1.42. Check out the list of the most volatile stocks — is CSTONE PHARMACEUTICALS there?
CSPHF earnings for the last quarter are −0.02 USD per share, whereas the estimation was −0.04 USD resulting in a 41.38% surprise. The estimated earnings for the next quarter are −0.01 USD per share. See more details about CSTONE PHARMACEUTICALS earnings.
CSTONE PHARMACEUTICALS revenue for the last quarter amounts to 36.05 M USD despite the estimated figure of 49.05 M USD. In the next quarter revenue is expected to reach 52.60 M USD.
Yes, you can track CSTONE PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
CSPHF net income for the last quarter is −21.85 M USD, while the quarter before that showed −30.19 M USD of net income which accounts for 27.60% change. Track more CSTONE PHARMACEUTICALS financial stats to get the full picture.
Today CSTONE PHARMACEUTICALS has the market capitalization of 139.81 M, it has decreased by 13.71% over the last week.
No, CSPHF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CSPHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CSTONE PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CSTONE PHARMACEUTICALS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CSTONE PHARMACEUTICALS stock shows the sell signal. See more of CSTONE PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CSTONE PHARMACEUTICALS future price: according to them, CSPHF price has a max estimate of 0.37 USD and a min estimate of 0.37 USD. Read a more detailed CSTONE PHARMACEUTICALS forecast: see what analysts think of CSTONE PHARMACEUTICALS and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CSTONE PHARMACEUTICALS EBITDA is −77.17 M USD, and current EBITDA margin is −118.01%. See more stats in CSTONE PHARMACEUTICALS financial statements.